Fevaxyn Pentofel, Suspension for Injection for Cats

Nchi: Uingereza

Lugha: Kiingereza

Chanzo: VMD (Veterinary Medicines Directorate)

Viambatanisho vya kazi:

Chlamydophila felis, Feline calicivirus, Feline leukemia virus, Feline panleukopenia virus, Feline viral rhinotracheitis virus

Inapatikana kutoka:

Zoetis UK Limited

ATC kanuni:

QI06AL01

INN (Jina la Kimataifa):

Chlamydophila felis, Feline calicivirus, Feline leukemia virus, Feline panleukopenia virus, Feline viral rhinotracheitis virus

Dawa fomu:

Solution for injection

Dawa ya aina:

POM-V - Prescription Only Medicine – Veterinarian

Kundi la matibabu:

Cats

Eneo la matibabu:

Inactivated Viral and Bacterial Vaccine

Idhini hali ya:

Authorized

Idhini ya tarehe:

1997-02-05

Tabia za bidhaa

Issued: May 2022
AN: 02508/2021
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Fevaxyn Pentofel, suspension for injection for cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Per dose of 1 ml (single dose syringe):
ACTIVE COMPONENTS
RELATIVE POTENCY (R.P.)
Inactivated feline panleucopenia virus, strain
CU4
Inactivated feline calicivirus, strain 255
Inactivated feline rhinotracheitis virus, strain
605
Inactivated _Chlamydophila felis_,_ _strain_ _Cello
Inactivated feline leukaemia virus, strain 61E
≥ 8.50
≥ 1.26
≥ 1.39
≥ 1.69
≥ 1.45
ADJUVANTS
Ethylene/maleic anhydride (EMA-31)
Neocryl
Emulsigen SA
1% (v/v)
3% (v/v)
5% (v/v)
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Suspension for injection.
Vaccine appearance is a pale milky pink liquid which should be free
from solid particles.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the active immunisation of healthy cats 9 weeks or older against
feline panleucopenia
and feline leukaemia viruses and against respiratory diseases caused
by feline
rhinotracheitis virus, feline calicivirus and _Chlamydophila felis._
Issued: May 2022
AN: 02508/2021
Page 2 of 5
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Vaccination does not affect the course of feline leukaemia virus
(FeLV) infection in cats
already infected with FeLV at the time of vaccination, implying that
such cats will excrete
FeLV irrespective of vaccination; consequently, these animals will
constitute a hazard to
susceptible cats in their environment. It is therefore recommended
that cats with a significant
risk of having been exposed to FeLV be tested for FeLV antigen prior
to vaccination. Test
negative animals can be vaccinated, while test-positive cats should be
isolated from other
cats and retested within 1–2 months. Cats positive at the second
testing should be
considered as being permanently infected with FeLV and should be
handled accordin